COMMODORE CAPITAL LP, Ten Percent Owner at Satsuma Pharmaceuticals, holds 4.40M shares in Vera Therapeutics (Ticker: VERA), holds 1.57M shares in VistaGen Therapeutics (Ticker: VTGN), holds 1.45M shares in Enliven Therapeutics (Ticker: ELVN). Most recently, COMMODORE CAPITAL LP Sold ― shares of Vera Therapeutics on Jan 12, 2024 for an estimated value of 18.90M.